192 related articles for article (PubMed ID: 12748677)
1. Epstein-Barr virus-associated B-cell lymphoproliferative disorder in CLL patients after treatment with fludarabine and cyclophosphamide followed by high-dose chemotherapy with autologous stem cell transplantation.
Jindra P; Koza V; Boudová L; Vozobulová V; Cerná K; Karas M; Lysák D; Svojgrová M
Bone Marrow Transplant; 2003 May; 31(10):951-2. PubMed ID: 12748677
[No Abstract] [Full Text] [Related]
2. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
[TBL] [Abstract][Full Text] [Related]
3. Monitoring for cytomegalovirus and Epstein-Barr virus infection in chronic lymphocytic leukemia patients receiving i.v. fludarabine-cyclophosphamide combination and alemtuzumab as consolidation therapy.
Orlandi EM; Baldanti F; Citro A; Pochintesta L; Gatti M; Lazzarino M
Haematologica; 2008 Nov; 93(11):1758-60. PubMed ID: 18790800
[No Abstract] [Full Text] [Related]
4. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
Gross TG; Bucuvalas JC; Park JR; Greiner TC; Hinrich SH; Kaufman SS; Langnas AN; McDonald RA; Ryckman FC; Shaw BW; Sudan DL; Lynch JC
J Clin Oncol; 2005 Sep; 23(27):6481-8. PubMed ID: 16170157
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment for EBV-associated lymphoproliferative disease].
Kawa K
Nihon Rinsho; 2006 Mar; 64 Suppl 3():682-6. PubMed ID: 16615559
[No Abstract] [Full Text] [Related]
6. Autologous CD34+ cells transplantation after FAMP treatment in a patient with CLL and persisting AIHA: complete remission of lymphoma with control of autoimmune complications.
Jindra P; Koza V; Fiser J; Vozobulová V; Svojgrová M
Bone Marrow Transplant; 1999 Jul; 24(2):215-7. PubMed ID: 10455354
[TBL] [Abstract][Full Text] [Related]
7. Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development.
Weinstock DM; Ambrossi GG; Brennan C; Kiehn TE; Jakubowski A
Bone Marrow Transplant; 2006 Mar; 37(6):539-46. PubMed ID: 16462755
[TBL] [Abstract][Full Text] [Related]
8. Richter's transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis.
Thornton PD; Bellas C; Santon A; Shah G; Pocock C; Wotherspoon AC; Matutes E; Catovsky D
Leuk Res; 2005 Apr; 29(4):389-95. PubMed ID: 15725472
[TBL] [Abstract][Full Text] [Related]
9. Mobilization of peripheral blood stem cells in CLL patients after front-line fludarabine treatment.
Lysak D; Koza V; Steinerova K; Jindra P; Vozobulova V; Schutzova M
Ann Hematol; 2005 Jul; 84(7):456-61. PubMed ID: 15770494
[TBL] [Abstract][Full Text] [Related]
10. Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT.
Dreger P; Glass B; Seyfarth B; Humpe A; Claviez A; von Neuhoff N; Suttorp M; Schoch R; Schmitz N
Bone Marrow Transplant; 2000 Dec; 26(12):1361-2. PubMed ID: 11223980
[No Abstract] [Full Text] [Related]
11. Autologous blood cell transplantation in B-CLL: response to chemotherapy prior to mobilization predicts the stem cell yield.
Itälä M; Pelliniemi TT; Rajamäki A; Remes K
Bone Marrow Transplant; 1997 Apr; 19(7):647-51. PubMed ID: 9156240
[TBL] [Abstract][Full Text] [Related]
12. Intensive radio-chemotherapy with peripheral blood stem cell transplantation in young patients with chronic lymphocytic leukemia.
Bastion Y; Felman P; Dumontet C; Espinouse D; Coiffier B
Bone Marrow Transplant; 1992 Nov; 10(5):467-8. PubMed ID: 1464012
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus reactivation is a potentially severe complication in chronic lymphocytic leukemia patients with poor prognostic biological markers and fludarabine refractory disease.
Rath J; Geisler C; Christiansen CB; Hastrup N; Madsen HO; Andersen MK; Pedersen LB; Jurlander J
Haematologica; 2008 Sep; 93(9):1424-6. PubMed ID: 18641020
[No Abstract] [Full Text] [Related]
14. Polyclonal Epstein-Barr virus-associated lymphoproliferative disorder following autografting for chronic myeloid leukemia.
Shepherd JD; Gascoyne RD; Barnett MJ; Coghlan JD; Phillips GL
Bone Marrow Transplant; 1995 Apr; 15(4):639-41. PubMed ID: 7655394
[TBL] [Abstract][Full Text] [Related]
15. Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
Adiga GU; Abebe L; Wiernik PH
Am J Hematol; 2003 Apr; 72(4):267-73. PubMed ID: 12666139
[TBL] [Abstract][Full Text] [Related]
16. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
[TBL] [Abstract][Full Text] [Related]
17. Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.
Flinn IW; Neuberg DS; Grever MR; Dewald GW; Bennett JM; Paietta EM; Hussein MA; Appelbaum FR; Larson RA; Moore DF; Tallman MS
J Clin Oncol; 2007 Mar; 25(7):793-8. PubMed ID: 17283364
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous Richter's syndrome, prognosis, and clinical, histological and immunohistological patterns: report of four cases and review of the literature.
Duong T; Grange F; Auffret N; Aractingi S; Bodemer C; Brousse N; Hermine O; Fraitag S
Dermatology; 2010; 220(3):226-33. PubMed ID: 20145381
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma.
Tam CS; Wolf M; Prince HM; Januszewicz EH; Westerman D; Lin KI; Carney D; Seymour JF
Cancer; 2006 Jun; 106(11):2412-20. PubMed ID: 16649223
[TBL] [Abstract][Full Text] [Related]
20. [Characteristics of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease].
Kawa K
Rinsho Ketsueki; 2008 Jun; 49(6):390-6. PubMed ID: 18646606
[No Abstract] [Full Text] [Related]
[Next] [New Search]
